These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 3292210)
1. Drug treatment of stroke. Current status and future prospects. Sila CA; Furlan AJ Drugs; 1988 Apr; 35(4):468-76. PubMed ID: 3292210 [TBL] [Abstract][Full Text] [Related]
2. The utility of cardiovascular drugs in the treatment of cerebrovascular disease. Bösel J; Amiri H Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696 [TBL] [Abstract][Full Text] [Related]
3. [Use of vasoactive preparations with middle-aged and elderly patients with sequelae of cerebral circulatory disorders]. Man'kovskiĭ NB; Kostiuchenko VG Vrach Delo; 1987 Apr; (4):51-5. PubMed ID: 3617640 [No Abstract] [Full Text] [Related]
5. [Current status in the therapy of ischemic cerebrovascular disorders]. Regli F; Ganslmayer M Schweiz Rundsch Med Prax; 1989 Dec; 78(50):1414-20. PubMed ID: 2688021 [TBL] [Abstract][Full Text] [Related]
6. [Cardioneurology: the up-to-date key positions and the future prospects]. Suslina ZA; Foniakin AV; Geraskina LA Vestn Ross Akad Med Nauk; 2012; (2):4-10. PubMed ID: 22642172 [TBL] [Abstract][Full Text] [Related]
7. Hypertension and stroke: opportunities for prevention and prospects for protection. Reid JL J Hypertens Suppl; 1993 Dec; 11(5):S2-6. PubMed ID: 8158342 [TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic disorders and means of their pharmacological correction in cerebral infarction in patients with ischemic heart disease]. Vinichuk SM Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1658-63. PubMed ID: 3434066 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease. Capodanno D; Alberts M; Angiolillo DJ Nat Rev Cardiol; 2016 Oct; 13(10):609-22. PubMed ID: 27489191 [TBL] [Abstract][Full Text] [Related]
10. Cost considerations in the pharmacological prevention and treatment of stroke. Alexandrov AV; Smurawska LT; Bartle W; Oh P Pharmacoeconomics; 1997 May; 11(5):408-18. PubMed ID: 10168030 [TBL] [Abstract][Full Text] [Related]
11. Targeting heart failure with preserved ejection fraction: current status and future prospects. Kanwar M; Walter C; Clarke M; Patarroyo-Aponte M Vasc Health Risk Manag; 2016; 12():129-41. PubMed ID: 27143907 [TBL] [Abstract][Full Text] [Related]
12. [Use of mildronate for the treatment of patients with circulatory encephalopathy against a background of stenosis of major arteries of the head]. Dziak LA; Golik VA Lik Sprava; 2003; (5-6):98-101. PubMed ID: 14618818 [TBL] [Abstract][Full Text] [Related]
13. Trends and future developments in the pharmacological treatment of acute ischaemic stroke. del Zoppo GJ; Wagner S; Tagaya M Drugs; 1997 Jul; 54(1):9-38. PubMed ID: 9211077 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of arterial disease in very elderly people: results from a prospective registry (FRENA). López-Jiménez L; Camafort M; Tiberio G; Carmona JA; Guijarro C; Martínez-Peñalver F; Monreal M; Angiology; 2008; 59(4):427-34. PubMed ID: 18388061 [TBL] [Abstract][Full Text] [Related]
15. [Mildronat--treatment of cardio-neurologic pathology in ischemia and hypoxia]. Afanas'ev VV; Murashko NK Lik Sprava; 2012; (7):68-74. PubMed ID: 23350117 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group. Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985 [TBL] [Abstract][Full Text] [Related]
20. The Carotid and Middle cerebral artery Occlusion Surgery Study (CMOSS): a study protocol for a randomised controlled trial. Ma Y; Gu Y; Tong X; Wang J; Kuai D; Wang D; Ren J; Duan L; Maimaiti A; Cai Y; Huang Y; Wang X; Cao Y; You C; Yu J; Jiao L; Ling F Trials; 2016 Nov; 17(1):544. PubMed ID: 27852286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]